Companies
Medtronic
Medical devicesGalway, IrelandMDTOver 95,000 employees
More about Medtronic
Medical device company that makes cardiac, neurological, surgical and diabetes devices used by hospitals and patients worldwide.
Revenue
$36.4B
Fiscal 2026 (ended April), up about 8%
Employees
Over 95,000
As of April 2026, full-time
Stock
MDT
New York Stock Exchange
Headquarters
Galway, Ireland
Principal executive offices per fiscal 2026 10-K
CEO
Geoff Martha
Since April 2020, chairman since December 2020
Main businessesCardiovascular, Neuroscience, Medical Surgical; majority stake in MiniMed (diabetes)
Current strategySeparating its diabetes business into MiniMed, which held its IPO in March 2026, and focusing on innovation-driven growth in cardiovascular, neuroscience and surgical devices
Recent workforce changesRestructuring approved in December 2025 tied to the MiniMed separation, with $300M to $500M in expected charges and $136M in employee termination costs in fiscal 2026
CompetitorsAbbott, Boston Scientific, Stryker
Related companiesAbbottBoston ScientificStryker
Checked October 11, 2026 · Sources: sec.gov
No source-backed updates for Medtronic yet. They appear here when a public report or filing covers the company.
No one has posted about Medtronic yet. Be the first to post ›
Follow Medtronic in a feed reader, no account needed: RSS feed